Central Pharmaceutical JSC No. 3

74
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DP36
VND
63,000.00
200 (0.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Central Pharmaceutical JSC No. 3 Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
192,855.00
151,915.00
157,003.00
136,489.00
116,488.00
142,959.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
-25,679.00
0.00
0.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
252,867.00
108,769.00
166,310.00
116,110.00
96,664.00
132,916.00
Cash Flow from Investing Activities
-143,001.00
-28,182.00
-118,296.00
-69,874.00
-42,282.00
-83,242.00
Cash Flow from Financing Activities
-119,097.00
-72,255.00
-63,747.00
-49,857.00
-70,585.00
-63,260.00
Net Cash Inflow / Outflow
-9,230.00
8,331.00
-15,730.00
-3,595.00
-16,216.00
-13,590.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
2.00
25.00
-12.00
-3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Central Pharmaceutical JSC No. 3
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Profit Before Tax
192855.142345
324640.661378
-1,31,785.00
-40.59%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0
-158763.242086
1,58,763.00
100.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
252867.462111
189767.309031
63,100.00
33.25%
Cash Flow from Investing Activities
-143001.79006
-193121.409984
50,120.00
25.95%
Cash Flow from Financing Activities
-119097.627116
-155542.528037
36,445.00
23.43%
Net Cash Inflow / Outflow
-9230.771295
-158788.386012
1,49,558.00
94.19%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.18377
108.242978
-107.00
-98.91%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 132.48% vs -34.60% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
2,52,867.46
1,08,769.25
132.48%